Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13487359 | 0.92 | PDK2 (0.31) | PDK2 | |
| SCHEMBL13487109 | 0.91 | PIK3CA (0.32) | PDK2PIK3CA | |
| SCHEMBL13487282 | 0.90 | KDM4E (0.34) | CYP17A1 | |
| SCHEMBL13487178 | 0.89 | MCL1 (0.32) | — | |
| SCHEMBL13487517 | 0.88 | PDK2 (0.32) | PDK2PIK3CAMAP4K4 | |
| SCHEMBL13487112 | 0.87 | SCN9A (0.36) | CYP17A1PDK2PIK3CA | |
| SCHEMBL13487900 | 0.87 | PDK2 (0.36) | PDK2PIK3CAMAP4K4 | |
| SCHEMBL13487050 | 0.86 | PDK2 (0.31) | PDK2 | |
| SCHEMBL13487137 | 0.86 | L3MBTL1 (0.32) | PDK2 | |
| SCHEMBL13487114 | 0.85 | PDK2 (0.39) | CYP17A1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | CYP17A1 911/4885PDK2 1456/4885PIK3CA 3662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.